TY - JOUR
T1 - Malnutrition in head and neck cancer patients
T2 - Impacts and indications of a prophylactic percutaneous endoscopic gastrostomy
AU - Yanni, A.
AU - Dequanter, D.
AU - Lechien, J. R.
AU - Loeb, I.
AU - Rodriguez, A.
AU - Javadian, R.
AU - Van Gossum, M.
N1 - Publisher Copyright:
© 2019 Elsevier Masson SAS
PY - 2019/6/1
Y1 - 2019/6/1
N2 - Introduction: Head and neck cancer (HNC) patients often experience malnutrition before and during treatment. Prophylactic gastrostomy has emerged as an efficient tool for ensuring adequate nutrition. However, there is no suitable algorithm able to identify patients at high risk of malnutrition. The aim of this study was to describe the nutritional management, to assess the impact of prophylactic gastrostomy, and to identify predictors of malnutrition. Methods: This retrospective study included 152 patients treated with surgery, radiotherapy, or chemotherapy for HNC. The patients were classified according to their gastrostomy status (prophylactic or non-prophylactic). Nutritional, tumoral and treatment characteristics were reported. Clinical and nutritional outcomes were measured 6 weeks after the beginning of treatment. In order to describe the nutritional management and the impact of prophylactic gastrostomy on patients, univariate analysis was generated using chi-square test and Mann–Whitney test or Student's t-test. Logistic regression was performed to identify factors associated with malnutrition. Results: Forty-one patients received prophylactic gastrostomy whereas 111 patients had no nutritional support. Prophylactic gastrostomy placement was associated with a lower initial body mass index, with severe malnutrition, and with initial oral intake disorder. Patients who did not experienced prophylactic gastrostomy had much worse outcomes such as hospital readmissions (P = 0.042), relative weight loss at 6 weeks (P < 0.0001), dysphagia, severe malnutrition, and poor state of health (P = 0.001). Our complication rates (4.9%) were lower than the usual range (5.9–9.3%) and no life-threatening complication was reported. Positive N status, oral intake disorder, concomitant radiochemotherapy, nasopharyngeal, and hypopharyngeal tumor site were significant predictive factors for malnutrition. Conclusions: Prophylactic percutaneous endoscopic gastrostomy showed advantages in terms of hospital readmissions, relative weight loss at 6 weeks, dysphagia, severe malnutrition, and poor state of health. Tumoral, nutritional and treatment characteristics seem to be predictors for malnutrition. Hence, physicians should integrate these factors in their nutrition algorithm approach.
AB - Introduction: Head and neck cancer (HNC) patients often experience malnutrition before and during treatment. Prophylactic gastrostomy has emerged as an efficient tool for ensuring adequate nutrition. However, there is no suitable algorithm able to identify patients at high risk of malnutrition. The aim of this study was to describe the nutritional management, to assess the impact of prophylactic gastrostomy, and to identify predictors of malnutrition. Methods: This retrospective study included 152 patients treated with surgery, radiotherapy, or chemotherapy for HNC. The patients were classified according to their gastrostomy status (prophylactic or non-prophylactic). Nutritional, tumoral and treatment characteristics were reported. Clinical and nutritional outcomes were measured 6 weeks after the beginning of treatment. In order to describe the nutritional management and the impact of prophylactic gastrostomy on patients, univariate analysis was generated using chi-square test and Mann–Whitney test or Student's t-test. Logistic regression was performed to identify factors associated with malnutrition. Results: Forty-one patients received prophylactic gastrostomy whereas 111 patients had no nutritional support. Prophylactic gastrostomy placement was associated with a lower initial body mass index, with severe malnutrition, and with initial oral intake disorder. Patients who did not experienced prophylactic gastrostomy had much worse outcomes such as hospital readmissions (P = 0.042), relative weight loss at 6 weeks (P < 0.0001), dysphagia, severe malnutrition, and poor state of health (P = 0.001). Our complication rates (4.9%) were lower than the usual range (5.9–9.3%) and no life-threatening complication was reported. Positive N status, oral intake disorder, concomitant radiochemotherapy, nasopharyngeal, and hypopharyngeal tumor site were significant predictive factors for malnutrition. Conclusions: Prophylactic percutaneous endoscopic gastrostomy showed advantages in terms of hospital readmissions, relative weight loss at 6 weeks, dysphagia, severe malnutrition, and poor state of health. Tumoral, nutritional and treatment characteristics seem to be predictors for malnutrition. Hence, physicians should integrate these factors in their nutrition algorithm approach.
KW - Cancer
KW - Endoscopic
KW - Gastrostomy
KW - Head
KW - Malnutrition
KW - Neck
UR - http://www.scopus.com/inward/record.url?scp=85062299753&partnerID=8YFLogxK
U2 - 10.1016/j.anorl.2019.01.001
DO - 10.1016/j.anorl.2019.01.001
M3 - Article
C2 - 30846293
AN - SCOPUS:85062299753
SN - 1879-7296
VL - 136
SP - S27-S33
JO - European Annals of Otorhinolaryngology, Head and Neck Diseases
JF - European Annals of Otorhinolaryngology, Head and Neck Diseases
IS - 3
ER -